When patients’ lives are at the center of what you do, experience matters
We have the relationships, knowledge and experience you need to successfully develop and deliver your cellular therapy.
About UsDiscovery
Customizable research and cell sourcing solutions
Preclinical and Clinical
Solutions to help bring your cellular therapy from preclinical development through to commercialization
Commercial
Your cell supply chain and cell sourcing solutions
For 30 years, our parent company, the National Marrow Donor Program® (NMDP)/Be The Match®, has matched donors and patients, and used personalized end-to-end case management to facilitate the collection, tracking and delivery of cells around the world.
We’re extending these proven solutions to organizations developing and delivering new autologous and allogeneic cellular therapies to patients. Whether your cellular therapy is in discovery, clinical trials or ready for commercialization, we offer customizable solutions to meet your needs.
Cell Lines Blog →
CAR-T 2.0
The quest to develop allogeneic CAR-T therapies
The crucial role in delivering effective cell and gene therapies
How standardization can overcome challenges in apheresis
In-the-News: May 2018
As cell therapies boom, ISCT attendees focus on commercialization logistics
Q&A With Be The Match BioTherapies Director of Product Development Operations, Dr. Jamie Margolis
19
million people in world’s largest registry80,000
cellular transplants facilitated worldwide over the past 30 years22,000
cell and blood shipments managed annually around the world“If the services and expertise we’ve built over the course of our history can help patients in new ways, we feel it’s our obligation to help.”
— Jeffrey Chell, M.D., CEO Emeritus, NMDP/Be The Match and Be The Match BioTherapies®